Ultra-processed foods may raise the risk of type 2 diabetes
New research finds an association between ultra-processed foods and the risk of type 2 diabetes and lays out a few possible explanations for this link.
Related Articles
Bariatric Surgery More Effective and Durable Than New Obesity Drugs and Lifestyle Intervention
SAN DIEGO – June 11, 2024 – Systematic reviews* of medical literature between 2020 to 2024 show bariatric surgery, also known as metabolic or weight-loss…
Gut microbiota-derived short-chain fatty acids and their role in human health and disease
Nature Reviews Microbiology – The human intestinal microbiota ferments dietary fibre to short-chain fatty acids, which make an important contribution to host health. In this…
GLP-1RA in the Real World: 1-year Compliance and Outcomes… : Annals of Surgery
e to factors such as costs, drug availability, insurance coverage, and adverse events. Methods: A retrospective series of patients with obesity prescribed semaglutide at a…
Postoperative Outcomes in Super- and Super-Super Obese Patients Undergoing Emergency Abdominal Surgery
With a rising prevalence of Class III obesity (BMI >40), it is crucial to identify the perioperative risks associated with super-obesity (BMI 50-59.9) and super-super-obesity…
Weight stigma and bias: standards of care in overweight and obesity—2025
Weight bias involves negative attitudes and stereotypes towards individuals based on their weight, which can be explicit or implicit. This bias contributes to weight stigma,…
Introduction and methodology: Standards of Care in Overweight and Obesity—2025
Obesity is a chronic, relapsing, and progressive disease requiring long-term, interprofessional treatment strategies to improve health outcomes. With over 40% of US adults and nearly…
Semaglutide May Cut Cardiovascular Risk Before Weight Loss
In SELECT, semaglutide was associated with a 41% reduction in major CV events within 6 months — ie, before weight loss or full dosing was…
Neoadjuvant Semaglutide, Weight Loss, and Overall Outcomes
This case-control study examines the use of glucagon-like peptide-1 receptor agonist before metabolic and bariatric surgery and its postoperative outcome.
Medication Use Before and After Different Bariatric Surgery Procedures: Results from a Population-Based Cohort Study
Obesity Surgery – Metabolic and bariatric surgery improves most obesity-related comorbidities. Here, we evaluate the effect of different metabolic and bariatric surgery interventions on the…